Ankur Jain

16PUBLICATIONS
5CO-AUTHORS
Oncology and carcinogenesis not elsewhere classifiedMedical mycologyCancer therapy (excl. chemotherapy and radiation therapy)HaematologyAllergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Apr 27, 2026
Inferior Outcomes of p230-CML with Imatinib: a Report of 2 Cases of p210/p230 Co-Expressed CML Showing Rapid Progression To Leukaemia Cutis along with the Systematic Review.

|Nov 22, 2025
Eyelid myeloid sarcoma heralding relapse of acute myeloid leukemia in a child: First report from India and literature review.

Ankur Jain, Pooja Prasad, Sumita Chaudhry

|Mar 27, 2025
Extranodal NK/T-Cell Lymphoma, Nasal Type

Ankur Jain

|Feb 07, 2025
Efficacy and Safety of Weekly Bortezomib-dexamethasone as the Third-Line Therapy for Warm Autoimmune Hemolytic Anemia: a Case Series of 5 Patients.

Ankur Jain, Aditi Jain, Sumita Chaudhry

|Mar 14, 2022
Imatinib-induced generalized vitiligo.

Ankur Jain

|Jul 16, 2021
Does Mesenchymal Stromal Cell Count in Pre-autologous Hematopoietic Stem Cell Transplant Peripheral Blood and Apheresis Product Predict for Infectious Complications in the Post-transplant Period?

Ankur Jain, Alka Khadwal, Man Updesh Singh Sachdeva

Pageof 3

Frequent Collaborators

1 joint publications

Man Updesh Singh Sachdeva

1 joint publications

Deepesh Lad

1 joint publications

Neelam Varma

1 joint publications

Pooja Prasad